RUNX1 and acute myeloid leukemia: In this study, we found that the top activated pathways in the TRH-high group of RUNX1-RUNX1T1 AML were the oxidative phosphorylation pathway, the citrate cycle, the TCA cycle pathway, and the alanine aspartate and glutamate metabolism pathway.